AI assistant
IDEXX LABORATORIES INC /DE — Director's Dealing 2013
Feb 5, 2013
30016_dirs_2013-02-05_df810c47-586b-4f51-b490-2b8850bdcfe0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2013-02-01
Reporting Person: RAINES MERILEE (Executive VP & CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-02-01 | Common Stock | M | 13581 | $34.3700 | Acquired | 51581 | Direct |
| 2013-02-01 | Common Stock | S | 13581 | $94.4108 | Disposed | 38000 | Direct |
| 2013-02-01 | Common Stock | S | 31900 | $94.7466 | Disposed | 6100 | Direct |
| 2013-02-01 | Common Stock | S | 6100 | $95.8640 | Disposed | 0 | Direct |
| 2013-02-01 | Common Stock | S | 29052 | $94.7439 | Disposed | 5948 | Indirect |
| 2013-02-01 | Common Stock | S | 5948 | $95.8086 | Disposed | 0 | Indirect |
| 2013-02-04 | Common Stock | M | 20440 | $41.9350 | Acquired | 20440 | Direct |
| 2013-02-04 | Common Stock | M | 26000 | $28.6550 | Acquired | 46440 | Direct |
| 2013-02-04 | Common Stock | M | 24000 | $25.4500 | Acquired | 70440 | Direct |
| 2013-02-04 | Common Stock | M | 17736 | $56.9500 | Acquired | 88176 | Direct |
| 2013-02-04 | Common Stock | M | 1 | $34.3700 | Acquired | 88177 | Direct |
| 2013-02-04 | Common Stock | M | 8120 | $53.3100 | Acquired | 96297 | Direct |
| 2013-02-04 | Common Stock | M | 2851 | $77.5900 | Acquired | 99148 | Direct |
| 2013-02-04 | Common Stock | S | 84486 | $93.6295 | Disposed | 14662 | Direct |
| 2013-02-04 | Common Stock | S | 4862 | $94.3454 | Disposed | 9800 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-02-01 | Non-Qualified Stock Option (right to buy) | $34.3700 | M | 13581 | Disposed | 2016-02-13 | Common Stock (13581) | Direct |
| 2013-02-04 | Incentive Stock Option (right to buy) | $41.9350 | M | 2384 | Disposed | 2014-02-13 | Common Stock (2384) | Direct |
| 2013-02-04 | Incentive Stock Option (right to buy) | $28.6550 | M | 3488 | Disposed | 2015-02-02 | Common Stock (3488) | Direct |
| 2013-02-04 | Incentive Stock Option (right to buy) | $25.4500 | M | 3928 | Disposed | 2014-02-04 | Common Stock (3928) | Direct |
| 2013-02-04 | Non-Qualified Stock Option (right to buy) | $28.6550 | M | 22512 | Disposed | 2015-02-02 | Common Stock (22512) | Direct |
| 2013-02-04 | Non-Qualified Stock Option (right to buy) | $41.9350 | M | 18056 | Disposed | 2014-02-13 | Commom Stock (18056) | Direct |
| 2013-02-04 | Non-Qualified Stock Option (right to buy) | $56.9500 | M | 17736 | Disposed | 2015-02-13 | Common Stock (17736) | Direct |
| 2013-02-04 | Incentive Stock Option (right to buy) | $34.3700 | M | 1 | Disposed | 2016-02-13 | Common Stock (1) | Direct |
| 2013-02-04 | Non-Qualified Stock Option (right to buy) | $53.3100 | M | 8120 | Disposed | 2017-02-13 | Common Stock (8120) | Direct |
| 2013-02-04 | Non-Qualified Stock Option (right to buy) | $77.5900 | M | 2851 | Disposed | 2018-02-13 | Common Stock (2851) | Direct |
| 2013-02-04 | Non-Qualified Stock Option (right to buy) | $25.4500 | M | 20072 | Disposed | 2014-02-04 | Common Stock (20072) | Direct |
Footnotes
F1: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $94.24 to $94.64, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1, 2, 3, 4, 5, 6 and 7 to this Form 4.
F2: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $94.22 to $95.21, inclusive.
F3: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $95.22 to $96.18, inclusive.
F4: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $94.24 to $95.23, inclusive.
F5: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $95.24 to $96.19, inclusive.
F6: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $93.26 to $94.20, inclusive.
F7: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $94.28 to $94.46, inclusive.
F8: Grant of options to buy shares of common stock becomes exercisable as to 4,527 shares on 02/14/2010, 02/14/2011 and 02/14/2012, 4,526 shares on 02/14/2013, and the remaining 1,618 shares on 02/14/2014.
F9: Grant of options to buy shares of common stock that vest on the fifth anniversary date (02/14/2012) of the grant.
F10: Grant of options to buy shares of common stock that vest on the fifth anniversary date (02/03/2010) of the grant.
F11: Grant of options to buy shares of common stock that vest on the fifth anniversary date (02/05/2009) of the grant.
F12: Grant of options to buy shares of common stock becomes exercisable as to 5,200 shares on 02/03/2006, 02/03/2007, 02/03/2008, and 02/03/2009, and the remaining 1,712 shares on 02/03/2010.
F13: Grant of options to buy shares of common stock becomes exercisable as to 4,088 shares on 02/14/2008, 02/14/2009, 02/14/2010, and 02/14/2011, and the remaining 1,704 shares on 02/14/2012.
F14: Grant of options to buy shares of common stock becomes exercisable as to 4,434 shares on 02/14/2009, 02/14/2010, 02/14/2011, and 02/14/2012, and the remaining 2,678 shares on 02/14/2013.
F15: Grant of options to buy shares of common stock becomes exercisable as to 1 share on 02/14/2010 and 02/14/2013, and the remaining 2,909 shares on 02/14/2014.
F16: Grant of options to buy shares of common stock becomes exercisable as to 4,060 shares on 02/14/2011, 02/14/2012 and 02/14/2013, 4,059 shares on 02/14/2014, and the remaining 2,184 shares on 02/14/2015.
F17: Grant of options to buy shares of common stock becomes exercisable as to 2,851 shares on 02/14/2012, 02/14/2013, 02/14/2014 and 02/14/2015, and the remaining 1,563 shares on 02/14/2016.
F18: Grant of options to buy shares of common stock becomes exercisable as to 4,800 shares on 02/05/2005, 02/05/2006, 02/05/2007 and 02/05/2008, and the remaining 872 shares on 02/05/2009.